THE BRITISH SOCIETY FOR ORAL AND DENTAL RESEARCH
Support to training in Dental ResearchSupport for promotion and dissemination of information about Dental ResearchSupport for development of Dental Research
Objects
TO PROMOTE THE ADVANCEMENT OF RESEARCH IN ALL BRANCHES OF DENTAL SCIENCE, AND IN THE RELATED PHASES OF THE SCIENCE THAT CONTRIBUTE DIRECTLY TO THE DEVELOPMENT OF ORAL HEALTH. TO ENCOURAGE AND FACILITATE CO-OPERATIVE EFFORT AND ACHIEVEMENT, BY INVESTIGATORS IN ALL NATIONS IN EVERY BRANCH OF DENTAL SCIENCE, AND TO DISSEMINATE THE RESULTS OF RESEARCH TO THE PUBLIC.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net income of £52,019 for the year ended 31 December 2024, resulting in total funds of £591,141. The trustees confirm there are no material uncertainties regarding the charity's ability to continue as a going concern. The charity's reserves policy is to maintain sufficient levels to fulfill its objectives, with unrestricted funds totaling £570,698.
What the accounts disclose
“The BSODR Management Committee have a policy of maintaining sufficient level of reserves to enable the charity to fulfil its objectives.” — page 4
Trustees
- Dr Alexander Jon Cresswell-Boyes
- Dr Zoe Brookes
- Professor PAul Anderson
- Professor Rachel Waddington
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £68k | £46k |
| 31/12/2023 | £64k | £94k |
| 31/12/2022 | £43k | £22k |
| 31/12/2021 | £15k | £13k |
| 31/12/2020 | £30k | £31k |
Common questions
Is THE BRITISH SOCIETY FOR ORAL AND DENTAL RESEARCH financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net income of £52,019 for the year ended 31 December 2024, resulting in total funds of £591,141. The trustees confirm there are no material uncertainties regarding the charity's ability to continue as a going concern. The charity's reserves policy is to maintain sufficient levels to fulfill its objectives, with unrestricted funds totaling £570,698. Its FY2024 accounts were independently examined.